BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 23634887)

  • 81. Human papillomavirus infection and p16 overexpression in oropharyngeal squamous cell carcinoma: a case series from 2010 to 2014.
    Donà MG; Spriano G; Pichi B; Rollo F; Laquintana V; Covello R; Pellini R; Giuliani M; Pescarmona E; Benevolo M
    Future Microbiol; 2015; 10(8):1283-91. PubMed ID: 26228531
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients.
    Settle K; Posner MR; Schumaker LM; Tan M; Suntharalingam M; Goloubeva O; Strome SE; Haddad RI; Patel SS; Cambell EV; Sarlis N; Lorch J; Cullen KJ
    Cancer Prev Res (Phila); 2009 Sep; 2(9):776-81. PubMed ID: 19641042
    [TBL] [Abstract][Full Text] [Related]  

  • 83. HPV-Positive Oropharyngeal Cancer Via p16 Immunohistochemistry in Japan.
    Toman J; Von Larson S; Umeno H; Kurita T; Furusaka T; Hasegawa H; Prasad ML; Sasaki CT
    Ann Otol Rhinol Laryngol; 2017 Feb; 126(2):152-158. PubMed ID: 27913709
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications.
    Klussmann JP; Mooren JJ; Lehnen M; Claessen SM; Stenner M; Huebbers CU; Weissenborn SJ; Wedemeyer I; Preuss SF; Straetmans JM; Manni JJ; Hopman AH; Speel EJ
    Clin Cancer Res; 2009 Mar; 15(5):1779-86. PubMed ID: 19223504
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.
    Iyer NG; Dogan S; Palmer F; Rahmati R; Nixon IJ; Lee N; Patel SG; Shah JP; Ganly I
    Ann Surg Oncol; 2015 Dec; 22(13):4411-21. PubMed ID: 25801358
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trials.
    Mehanna H; Franklin N; Compton N; Robinson M; Powell N; Biswas-Baldwin N; Paleri V; Hartley A; Fresco L; Al-Booz H; Junor E; El-Hariry I; Roberts S; Harrington K; Ang KK; Dunn J; Woodman C
    Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E1863-9. PubMed ID: 26749143
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Clinicopathological characteristics of HPV(+) oropharyngeal squamous cell carcinoma].
    Zhao YH; Bai YP; Mao ML; Zhang H; Zhao XL; Yang DM; Wan HF; Liu HG
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):127-131. PubMed ID: 30695865
    [No Abstract]   [Full Text] [Related]  

  • 88. HPV-associated head and neck cancer: a virus-related cancer epidemic.
    Marur S; D'Souza G; Westra WH; Forastiere AA
    Lancet Oncol; 2010 Aug; 11(8):781-9. PubMed ID: 20451455
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Human papillomavirus types in cases of squamous cell carcinoma of head and neck in Colombia.
    Quintero K; Giraldo GA; Uribe ML; Baena A; Lopez C; Alvarez E; Sanchez GI
    Braz J Otorhinolaryngol; 2013; 79(3):375-81. PubMed ID: 23743755
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Association of Oral Human Papillomavirus DNA Persistence With Cancer Progression After Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.
    Fakhry C; Blackford AL; Neuner G; Xiao W; Jiang B; Agrawal A; Gillison ML
    JAMA Oncol; 2019 Jul; 5(7):985-992. PubMed ID: 31046104
    [TBL] [Abstract][Full Text] [Related]  

  • 91. HPV-related oropharyngeal squamous cell carcinomas: a comparison between three diagnostic approaches.
    Melkane AE; Mirghani H; Aupérin A; Saulnier P; Lacroix L; Vielh P; Casiraghi O; Griscelli F; Temam S
    Am J Otolaryngol; 2014; 35(1):25-32. PubMed ID: 24112760
    [TBL] [Abstract][Full Text] [Related]  

  • 92. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
    Rooper LM; Gandhi M; Bishop JA; Westra WH
    Oral Oncol; 2016 Apr; 55():11-6. PubMed ID: 27016012
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Prognostic importance of human papillomavirus (HPV) and p16 positivity in squamous cell carcinoma of the vulva treated with radiotherapy.
    Lee LJ; Howitt B; Catalano P; Tanaka C; Murphy R; Cimbak N; DeMaria R; Bu P; Crum C; Horowitz N; Matulonis U; Viswanathan AN
    Gynecol Oncol; 2016 Aug; 142(2):293-8. PubMed ID: 27210818
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma.
    Shi W; Kato H; Perez-Ordonez B; Pintilie M; Huang S; Hui A; O'Sullivan B; Waldron J; Cummings B; Kim J; Ringash J; Dawson LA; Gullane P; Siu L; Gillison M; Liu FF
    J Clin Oncol; 2009 Dec; 27(36):6213-21. PubMed ID: 19884544
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer.
    Ahn SM; Chan JY; Zhang Z; Wang H; Khan Z; Bishop JA; Westra W; Koch WM; Califano JA
    JAMA Otolaryngol Head Neck Surg; 2014 Sep; 140(9):846-54. PubMed ID: 25078109
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Staging and prognosis of oropharyngeal carcinoma according to the 8th Edition of the American Joint Committee on Cancer Staging Manual in human papillomavirus infection.
    Yamashita Y; Ikegami T; Hirakawa H; Uehara T; Deng Z; Agena S; Uezato J; Kondo S; Kiyuna A; Maeda H; Suzuki M; Ganaha A
    Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):827-836. PubMed ID: 30594962
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Concurrent HPV-related oropharyngeal carcinoma in four couples.
    Sathasivam HP; Bhatia R; Bradley P; Robson A; Paleri V; Cocks H; Oozeer N; Milne D; Sloan P; Robinson M
    Oral Oncol; 2018 Nov; 86():33-37. PubMed ID: 30409317
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Prevalence of high-risk human papillomavirus in oral squamous cell carcinoma with or without chewing habits.
    Anwar N; Chundriger Q; Awan S; Moatter T; Ali TS; Abdul Rasheed M; Pervez S
    PLoS One; 2024; 19(5):e0300354. PubMed ID: 38691559
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination.
    Schache AG; Liloglou T; Risk JM; Filia A; Jones TM; Sheard J; Woolgar JA; Helliwell TR; Triantafyllou A; Robinson M; Sloan P; Harvey-Woodworth C; Sisson D; Shaw RJ
    Clin Cancer Res; 2011 Oct; 17(19):6262-71. PubMed ID: 21969383
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The prognostic impact of human papillomavirus status following treatment failure in oropharyngeal cancer.
    Dave E; Ozbek U; Gupta V; Genden E; Miles B; Teng M; Posner M; Misiukiewicz K; Bakst RL
    PLoS One; 2017; 12(7):e0181108. PubMed ID: 28732044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.